Bullish Moving Averages
16
Bearish Moving Averages
0
Products
Investments
Back Stocks profile
Today’s low
354.00Today’s High
365.0052W low
211.0052W High
387.00Open Price
354.00Prev. Close
311.4000Volume
92827.00Value
33696201.00Market Cap Cr
3640.10
Price to Earnings
42.30
Price to Book Value
6.80
Dividend Yield
0.00
PE to Growth
5.20
Op Revenue TTM Cr
806.67
Net Profit TTM Cr
86.14
Cash From Operating Activity Cr
-7.46
Return on Equity %
16.17
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
03 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
367.33
Second Resistance
371.67
Third Resistance
378.33
First Support
356.33
Second Support
349.67
Third Support
345.33
Relative Strength Index
59.56
Money Flow Index
47.83
MACD
7.09
MACD Signal
7.8
Average True Range
14.68
Average Directional Index
18.1
Rate of Change (21)
15.33
Rate of Change (125)
15.4
Commodity Channel Index
40.6
Williams %R
-46.8
BETA
1 Month
0.91
3 Month
0.86
1 Year
0.72
3 Year
0.29
PRICE CHANGE ANALYSIS
1 Week
Low
High
343.8
365
1 Month
Low
High
278
386.95
3 Months
Low
High
278
386.95
6 Months
Low
High
277.65
386.95
1 Year
Low
High
211
386.95
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 195.87 | 202.20 | 215.21 | 195.90 | 173.66 | 178.23 | 175.65 | 165.65 | 162.23 | 173.60 | 194.44 | |
Operating Expenses Qtr | 160.77 | 165.32 | 175.50 | 159.54 | 140.89 | 144.08 | 142.22 | 132.10 | 130.67 | 139.35 | 158.31 | |
Operating Profit Qtr | 34.23 | 36.45 | 39.37 | 35.48 | 32.15 | 33.39 | 32.61 | 33.18 | 31.52 | 32.72 | 35.83 | |
EBIDT Qtr Cr | 35.11 | 36.88 | 39.70 | 36.36 | 32.77 | 34.15 | 33.43 | 33.55 | 31.56 | 34.25 | 36.13 | |
Depreciation Qtr | 4.34 | 4.14 | 4.30 | 4.24 | 5.92 | 4.74 | 4.56 | 4.37 | 4.33 | 4.48 | 4.20 | |
Net Profit Qtr | 20.05 | 22.26 | 23.21 | 20.62 | 18.11 | 20.34 | 20.21 | 21.05 | 20.26 | 21.03 | 23.34 | |
Basic EPS Qtr | 2.00 | 2.23 | 2.39 | 2.13 | 1.87 | 2.10 | 2.09 | 2.17 | 2.09 | 2.17 | 2.41 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 808.84 | 693.19 | 782.26 | 491.43 | 384.63 | |
Operating Expenses Annual Cr | 660.79 | 555.97 | 633.44 | 403.78 | 326.72 | |
Operating Profit Annual | 145.87 | 134.65 | 145.71 | 83.92 | 52.12 | |
Operating Profit Margin Annual % | 18.03 | 19.42 | 18.63 | 17.08 | 13.55 | |
Total Expenses Annual Cr | 693.17 | 586.47 | 655.42 | 433.72 | 354.50 | |
EBIDT Annual Cr | 148.05 | 137.23 | 148.82 | 87.65 | 57.91 | |
EBIDT Annual margin % | 18.30 | 19.80 | 19.02 | 17.84 | 15.06 | |
Depreciation | 17.02 | 22.28 | 17.13 | 16.31 | 13.86 | |
PAT Before ExtraOrdinary Items Annual Cr | 86.14 | 79.70 | 95.84 | 44.23 | 22.69 | |
Net Profit Annual | 86.14 | 79.70 | 95.84 | 44.23 | 22.69 | |
Basic EPS Annual | 8.74 | 8.22 | 9.89 | 4.56 | 2.34 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 532.56 | 347.81 | 269.12 | 173.44 | 129.32 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 187.93 | 225.14 | 65.30 | 54.96 | 38.42 | |
Total Current Liabilities Annual Cr | 372.05 | 288.21 | 186.98 | 163.66 | 239.77 | |
Total Capital Plus Liabilities Annual Cr | 1092.54 | 861.16 | 521.40 | 392.06 | 407.52 | |
Fixed Assets Annual | 465.95 | 329.16 | 156.04 | 113.37 | 113.19 | |
Total Non Current Assets Annual | 492.07 | 397.05 | 200.65 | 131.48 | 134.21 | |
Total Current Assets Annual | 600.47 | 464.11 | 320.75 | 260.58 | 273.31 | |
Total Assets Annual | 1092.54 | 861.16 | 521.40 | 392.06 | 407.52 | |
Contingent Liabilities plus Commitments Annual Cr | - | 27.87 | 100.51 | 16.20 | 47.46 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | -7.46 | -26.59 | 104.44 | 89.06 | 47.10 | |
Cash from Investing Activity Annual | -102.40 | -190.73 | -95.94 | -8.51 | -42.53 | |
Cash from Financing Annual Activity | 82.38 | 234.31 | -3.10 | -78.62 | -4.21 | |
Net Cash Flow Annual | - | 16.99 | 5.41 | 1.94 | 0.36 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 53.11 | 35.88 | 27.76 | 17.89 | 13.34 | |
ROE Annual % | 16.17 | 22.91 | 35.61 | 25.50 | 17.54 | |
ROCE Annual % | 18.18 | 20.06 | 39.37 | 31.23 | 26.25 | |
Total Debt to Total Equity Annual | 0.60 | 0.90 | 0.23 | 0.30 | 0.87 | |
EBDIT Annual Margin % | 18.35 | 19.86 | 19.10 | 17.97 | 15.28 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Graph |
---|---|---|---|---|---|
Total Qtr Revenue cr | 195.87 | 202.20 | 215.21 | 195.56 | |
Operating Expenses Qtr | 160.77 | 165.32 | 175.50 | 159.20 | |
Operating Profit Qtr | 34.23 | 36.45 | 39.37 | 35.82 | |
EBIDT Qtr Cr | 35.11 | 36.88 | 39.70 | 36.36 | |
Depreciation Qtr | 4.34 | 4.14 | 4.30 | 4.24 | |
Net Profit Qtr | 20.05 | 22.26 | 23.21 | 20.62 | |
Basic EPS Qtr | 2.00 | 2.23 | 2.39 | 2.13 |
Indicator | Mar 2024 | Graph |
---|---|---|
Total Revenue Annual | 808.84 | |
Operating Expenses Annual Cr | 660.79 | |
Operating Profit Annual | 145.87 | |
Operating Profit Margin Annual % | 18.03 | |
Total Expenses Annual Cr | 693.17 | |
EBIDT Annual Cr | 148.05 | |
EBIDT Annual margin % | 18.30 | |
Depreciation | 17.02 | |
PAT Before ExtraOrdinary Items Annual Cr | 86.14 | |
Net Profit Annual | 86.14 | |
Basic EPS Annual | 8.74 |
Indicator | Mar 2024 | Graph |
---|---|---|
Total ShareHolders Funds Annual | 532.56 | |
Minority Interest Liability Annual Cr | 0.00 | |
Total Non Current Liabilities Annual Cr | 187.93 | |
Total Current Liabilities Annual Cr | 372.05 | |
Total Capital Plus Liabilities Annual Cr | 1092.54 | |
Fixed Assets Annual | 465.95 | |
Total Non Current Assets Annual | 492.06 | |
Total Current Assets Annual | 600.48 | |
Total Assets Annual | 1092.54 | |
Contingent Liabilities plus Commitments Annual Cr | - |
Indicator | Mar 2024 | Graph |
---|---|---|
Cash from Operating Activity Annual | -7.46 | |
Cash from Investing Activity Annual | -102.39 | |
Cash from Financing Annual Activity | 82.38 | |
Net Cash Flow Annual | - |
Indicator | Mar 2024 | Graph |
---|---|---|
Book Value Per Share Annual | 53.11 | |
ROE Annual % | 16.17 | |
ROCE Annual % | 18.18 | |
Total Debt to Total Equity Annual | 0.60 | |
EBDIT Annual Margin % | 18.35 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
Jayesh Pannalal Choksi | 24.62 | 74555099 | 0 | 0 |
Vipula Jayesh Choksi | 10.01 | 74555100 | 0 | 0 |
Pranav Jayesh Choksi | 7.25 | 74555101 | 0 | 0 |
Zircon Teconica Private Limited | 20.47 | 74555103 | 0 | 0 |
Gufic Private Limited | 10.16 | 74555104 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
Motilal Oswal Small Cap Fund | 1.05 | 74555107 |
Name | Holding Percent | Holding Id |
---|---|---|
Jagdish N Master | 1.57 | 74555119 |
HUF | 1.76 | 74555112 |
LLP | 0.73 | 74555113 |
Motilal Oswal Financial Services Ltd | 3.32 | 74555116 |
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Sep 21, 2023 | 0.1 | FINAL | - | Equity Share |
Aug 24, 2022 | 0.1 | FINAL | - | Equity Share |
Sep 09, 2021 | 0.1 | FINAL | - | Equity Share |
Nov 03, 2020 | 0.05 | FINAL | - | Equity Share |
Sep 20, 2019 | 0.05 | FINAL | - | Equity Share |
Sep 19, 2018 | 0.05 | FINAL | - | Equity Share |
Aug 28, 2017 | 0.05 | FINAL | - | Equity Share |
Sep 19, 2016 | 0.05 | FINAL | - | Equity Share |
Sep 22, 2015 | 0.05 | FINAL | - | Equity Share |
Sep 18, 2014 | 0.05 | FINAL | - | Equity Share |
Sep 02, 2013 | 0.05 | FINAL | - | Equity Share |
Aug 16, 2012 | 0.05 | FINAL | - | Equity Share |
Sep 16, 2011 | 0.05 | FINAL | - | Equity Share |
Sep 20, 2010 | 0.05 | FINAL | - | Equity Share |
Sep 17, 2009 | 0.05 | FINAL | - | Equity Share |
Dec 11, 2008 | 0.05 | FINAL | - | Equity Share |
Mar 19, 2008 | 0.05 | FINAL | - | Equity Share |
Sep 20, 2006 | 0.16 | FINAL | - | Equity Share |
Sep 22, 2005 | 0.22 | FINAL | - | Equity Share |
Sep 20, 2004 | 0.11 | FINAL | - | Equity Share |
Sep 19, 2003 | 0.11 | FINAL | - | Equity Share |
Sep 17, 2002 | - | FINAL | - | Equity Share |
Sep 10, 2001 | - | INTERIM | - | Equity Share |
Oct 19, 2000 | - | INTERIM | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Oct 29, 2002 | 10:1 | 2002-11-08 |
Ex-Date | Purpose | Notes |
---|---|---|
May 29, 2024 | Audited Results & Final Dividend | - |
Feb 14, 2024 | Quarterly Results | - |
Nov 09, 2023 | Quarterly Results | - |
Aug 11, 2023 | Quarterly Results & ESOP | - |
May 29, 2023 | Audited Results & Final Dividend | - |
Feb 10, 2023 | Quarterly Results | - |
Nov 11, 2022 | Quarterly Results | - |
Aug 11, 2022 | Quarterly Results | - |
May 20, 2022 | Audited Results & Final Dividend | - |
Feb 09, 2022 | Quarterly Results | - |
Nov 03, 2021 | Quarterly Results | - |
Aug 11, 2021 | Quarterly Results | - |
Jun 04, 2021 | Audited Results & Final Dividend | - |
Feb 08, 2021 | Quarterly Results | - |
Nov 12, 2020 | Quarterly Results | - |
Sep 14, 2020 | Quarterly Results | - |
Aug 18, 2020 | Others | - |
Jul 31, 2020 | Audited Results & Final Dividend | - |
Feb 13, 2020 | Quarterly Results | - |
Dec 03, 2019 | Quarterly Results | - |
Nov 14, 2019 | Quarterly Results | - |
Aug 13, 2019 | Quarterly Results | - |
May 30, 2019 | Audited Results | (Revised) |
May 29, 2019 | Audited Results | - |
Feb 13, 2019 | Quarterly Results | - |
Feb 01, 2019 | Others | - |
Nov 13, 2018 | Quarterly Results | - |
Oct 26, 2018 | Others | - |
Sep 20, 2018 | Scheme of Amalgamation | inter alia, to consider and approve the draft scheme of amalgamation of Gufic Lifesciences Private Limited ('Transferor Company') with Gufic Biosciences Limited. ('Transferee Company' or 'Company'). |
Aug 13, 2018 | Unaudited Financial Results | - |
Jun 20, 2018 | Others | To consider and review the status of the scheme of Amalgamation of Gufic Lifesciences Private Limited with Gufic Biosciences Limited and their respective shareholders & creditors, approved by the Com. |
May 29, 2018 | Audited Results & Dividend | - |
Feb 12, 2018 | Quarterly Results | - |
Dec 14, 2017 | Quarterly Results | - |
Nov 09, 2017 | Quarterly Results & Others | - |
Sep 14, 2017 | Quarterly Results | - |
May 29, 2017 | Audited Results & Dividend | - |
Apr 03, 2017 | Others | To consider amalgamation of M/s. Gufic Lifesciences Private Limited, a company registered under Companies Act, 1956 with M/s. Gufic Biosciences Limited. |
Feb 14, 2017 | Quarterly Results | - |
Nov 24, 2016 | Scheme of Amalgamation | - |
Nov 14, 2016 | Quarterly Results | Resignation of Mr. Ashok M. Tarale as an Independent Director of the Company w.e.f. November 14, 2016. |
Aug 12, 2016 | Quarterly Results | - |
May 30, 2016 | Audited Results & Dividend | Approved Appointment of Ms. Ami Naresh Shah as Company Secretary of the Company w.e.f. March 22, 2016 and re-designated as Company Secretary & Compliance Officer. |
Feb 11, 2016 | Quarterly Results | - |
Nov 09, 2015 | Quarterly Results | - |
Aug 14, 2015 | Quarterly Results | - |
May 29, 2015 | Audited Results & Final Dividend | - |
Feb 13, 2015 | Quarterly Results | - |
Nov 13, 2014 | Quarterly Results | - |
Aug 27, 2014 | Others | To consider and approve the Auditors Report and the Directors Report including the annexures thereon on the Audited Financial Results of the Company for the Financial Year 2013-2014. |
Aug 14, 2014 | Quarterly Results | - |
May 30, 2014 | Audited Results | - |
Feb 14, 2014 | Quarterly Results | - |
Nov 14, 2013 | Quarterly Results | - |
Oct 07, 2013 | Others | To consider the Registered Office of the Company be changed within the local limits. |
Sep 13, 2013 | Appointment of new Auditors | - |
Aug 12, 2013 | Quarterly Results | - |
May 30, 2013 | Audited Results & Dividend | - |
May 15, 2013 | Quarterly Results | - |
Feb 14, 2013 | Quarterly Results | - |
Nov 09, 2012 | Quarterly Results | - |
Oct 03, 2012 | Others | inter alia, to shift the registered office of the Company within local limits. |
Aug 14, 2012 | Quarterly Results | - |
Jul 10, 2012 | Dividend | - |
Jun 12, 2012 | Audited Results & Dividend | - |
May 15, 2012 | Quarterly Results | - |
Feb 14, 2012 | Quarterly Results | - |
Nov 14, 2011 | Quarterly Results | - |
Aug 30, 2011 | Audited Results & Dividend | - |
Aug 12, 2011 | Quarterly Results | - |
May 12, 2011 | Quarterly Results | - |
Feb 14, 2011 | Quarterly Results | - |
Nov 12, 2010 | Quarterly Results | - |
Aug 30, 2010 | Audited Results & Dividend | - |
Aug 11, 2010 | Quarterly Results | - |
May 07, 2010 | Quarterly Results | (Board meeting adjourned from 05/05/2010 to 07/05/2010) |
Jan 29, 2010 | Quarterly Results | - |
Oct 31, 2009 | Quarterly Results | - |
Aug 24, 2009 | Audited Results & Dividend | Board meeting adjourned from 20/08/2009 to 24/08/2009. |
Jul 31, 2009 | Quarterly Results | - |
Apr 30, 2009 | Quarterly Results | - |
Jan 31, 2009 | Quarterly Results | - |
Nov 14, 2008 | Audited Results & Dividend | - |
Oct 31, 2008 | Quarterly Results | - |
Jul 31, 2008 | Quarterly Results | - |
Apr 30, 2008 | Quarterly Results | - |
Mar 07, 2008 | General | - |
Jan 31, 2008 | Quarterly Results | - |
Oct 31, 2007 | Quarterly Results | - |
Jul 31, 2007 | Quarterly Results | - |
Apr 30, 2007 | Quarterly Results | - |
Jan 31, 2007 | Quarterly Results | - |
Oct 31, 2006 | Quarterly Results | - |
Sep 04, 2006 | Accounts & Dividend | (Revised) |
Jul 31, 2006 | Quarterly Results | - |
Apr 28, 2006 | Quarterly Results | - |
Jan 31, 2006 | Quarterly Results | - |
Oct 29, 2005 | Quarterly Results | - |
Aug 31, 2005 | Dividend & Accounts | - |
Jul 29, 2005 | Quarterly Results | - |
Jun 08, 2005 | Re-appointment of Director | - |
Apr 30, 2005 | Quarterly Results | - |
Jan 17, 2005 | Quarterly Results | - |
Oct 29, 2004 | Quarterly Results | - |
Aug 30, 2004 | Dividend & Accounts | - |
Jul 30, 2004 | Quarterly Results | - |
Apr 30, 2004 | Quarterly Results | - |
Jan 31, 2004 | Quarterly Results | - |
Oct 31, 2003 | Quarterly Results | - |
Jul 31, 2003 | Quarterly Results | - |
May 09, 2003 | Accounts & Dividend | - |
Apr 30, 2003 | Unaudited Financial Results | - |
Jan 31, 2003 | Quarterly Results | - |
Nov 30, 2002 | Half Yearly Results | - |
Oct 31, 2002 | Quarterly Results | - |
Aug 16, 2002 | Accounts | - |
Jul 31, 2002 | Quarterly Results | - |
Apr 30, 2002 | Quarterly Results | - |
Jan 31, 2002 | Quarterly Results | - |
Nov 30, 2001 | Half Yearly Results | - |
Oct 31, 2001 | Quarterly Results | - |
Aug 20, 2001 | Accounts & Dividend | - |
Jul 30, 2001 | Quarterly Results | - |
Apr 30, 2001 | Quarterly Results | - |
Feb 28, 2001 | Half Yearly Results | - |
Jan 25, 2001 | Quarterly Results | - |
Oct 30, 2000 | Quarterly Results | - |
Aug 23, 2000 | Dividend, Accounts & Bonus (Revised) | - |
Jul 17, 2000 | Accounts | - |
Jun 23, 2000 | Preferential Offer | - |
Apr 26, 2000 | Quarterly Results | - |
Jan 29, 2000 | Quarterly Results | - |
Oct 31, 1999 | Quarterly Results | - |
Jul 26, 1999 | Quarterly Results | - |
Jul 25, 1999 | Quarterly Results | - |
Jun 16, 1999 | Accounts | - |
Apr 28, 1999 | Quarterly Results | - |
Jan 15, 1999 | Quarterly Results | - |
Oct 24, 1998 | Quarterly Results | - |
Jul 17, 1998 | Quaterly Results | - |
May 15, 1998 | Accounts | - |
Oct 24, 1997 | Half Yearly Results | - |
Jun 11, 1997 | Accounts | - |
Ex-Date | Bonus Ratio | Record Date |
---|---|---|
Oct 19, 2000 | 5:2 | - |
GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding Notice for transfer of equity shares to Investor Education and Protection Fund (IEPF) Authority is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of completion of second term of Dr. Rabi Sahoo (DIN: 01237464), Independent Director of the Company is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Intimation of closure of trading window is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Grant Of Options Under Gufic Biosciences Limited Employee Stock Option Plan 2023 ('Gufic ESOP 2023')
Intimation of Grant of Options under Gufic Biosciences Limited Employee Stock Option Plan 2023 ("Gufic ESOP 2023") is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation for appointment of Mr. Kamal Kishore Sheth (DIN: 00194986) as an Additional Director (Non-Executive Independent Director) of the Company is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation for resignation of Mr. Dilip Ghosh (DIN: 00412406) from the position of Whole Time Director of the Company pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Meeting Held On Thursday, June 27, 2024
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. June 27, 2024, inter-alia, considered and approved the matters which is attached herewith. The meeting of the Board of Directors commenced at 04:00 p.m. and concluded at 05:00 p.m.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the details of meeting with the Analyst/ Institutional Investor.GUFIC BIOSCIENCES LTD. - 509079 - Clarification On Increase In Volume Of Security
Clarification on increase in volume of security is attached herewith.The latest market price of Gufic BioSciences Ltd. on NSE was Rs. 363.00 as of today.
The opening share price of Gufic BioSciences Ltd. was Rs. 354.00 as of today.
The 52-week high share price of Gufic BioSciences Ltd. was Rs. 387.00.
The 52 week low share price of Gufic BioSciences Ltd. was Rs. 211.00.
Gufic BioSciences Ltd. has a market cap of Rs. 3640.10 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Gufic BioSciences Ltd. is 5.20. Please refer to the Fundamentals section for further details.
The operating revenue for Gufic BioSciences Ltd. in the last FY was Rs. 806.67 crore. Please refer to the Financials section for further details.
The Net Profit for Gufic BioSciences Ltd. in the last FY was Rs. 86.14 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Gufic BioSciences Ltd. was on 2023-09-21 for Rs. 0.1 per share. According to today’s share price, the dividend yield of Gufic BioSciences Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.
The latest bonus issue declared by Gufic BioSciences Ltd. was as of 2000-10-19. The bonus ratio declared in this issue was 5:2. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Gufic BioSciences Ltd. was as of 2002-10-29. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Gufic BioSciences Ltd..